Literature DB >> 12078771

Right ventricular dysfunction and pulmonary valve replacement after correction of tetralogy of Fallot.

Frank T H de Ruijter1, Ineke Weenink, Francois J Hitchcock, Erik J Meijboom, Ger B W E Bennink.   

Abstract

BACKGROUND: Correction of tetralogy of Fallot often leads to pulmonary regurgitation, sometimes warranting pulmonary valve replacement, for which indications and timing to achieve optimal results are not yet clear. This retrospective study describes follow-up and reinterventions in our tetralogy of Fallot population.
METHODS: Review of all consecutive patients operated on for tetralogy of Fallot between 1977 and 2000 was conducted. Included are date and type of repair, Doppler echocardiography (two-dimensional echocardiography), electrocardiographs, reoperations, and physical condition.
RESULTS: Total repair was performed in 171 patients at a mean age 1.9 +/- 2.5 years, follow-up time counted 9.6 +/- 7.0 years. Right ventriculotomy was used in 92%, and transatrial ventricular septal defect closure was used in 8%; 74% received a transannular outflow patch. Twenty-year survival was 91%. Last follow-up electrocardiographs showed right bundle branch block in 67% and serious arrhythmias in 11%. Two-dimensional echocardiography demonstrated severe pulmonary insufficiency and dilated right ventricle in 31% and 38%, respectively, increasing with postrepair age (p < 0.001). Poor clinical condition (New York Heart Association class II+) and echocardiographic proof of right atrial dilatation (p = 0.012) and arrhythmias (p = 0.03) were significantly associated. Furthermore, the influence of residual hemodynamic lesions, such as a remaining ventricular septal defect or pulmonary stenosis, or right ventricular dilatation was important (p = 0.04). Reintervention was necessary in 32 patients (19%; 10-year freedom, 83%), including angioplasty for residual stenosis and pulmonary valve replacement. At a mean age of 9.2 years after correction, 14 patients received a homograft, and 2 patients received a heterograft. In 7 patients the right ventricle returned to normal dimensions and symptoms disappeared. The incidence of right ventricular dilatation was considerably higher (p = 0.020) in patients with a transannular patch; the transatrial approach showed the opposite (p = 0.03), and patients presented with lower QRS duration (p = 0.007), although no difference could be found between survival after both surgical techniques. Effects of early timing (correction < 6 months) on right ventricular dysfunction could not be established.
CONCLUSIONS: Severe right ventricular dilatation and pulmonary regurgitation secondary to outflow tract repair in tetralogy of Fallot are frequently occurring sequelae developing slowly over time. Indications for pulmonary valve replacement remain controversial because echocardiographic findings or arrhythmias are not always accompanied by deterioration of clinical condition. However, right atrial dilatation and additional hemodynamic lesions demand increased vigilance. Transatrial repair is associated with a favorable outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12078771     DOI: 10.1016/s0003-4975(02)03586-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  An ovine model of pulmonary insufficiency and right ventricular outflow tract dilatation.

Authors:  J Daniel Robb; Matthew A Harris; Masahito Minakawa; Evelio Rodriguez; Kevin J Koomalsingh; Takashi Shuto; Yoav Dori; Robert C Gorman; Joseph H Gorman; Matthew J Gillespie
Journal:  J Heart Valve Dis       Date:  2012-03

2.  In vitro study of flow regulation for pulmonary insufficiency.

Authors:  T A Camp; K C Stewart; R S Figliola; T McQuinn
Journal:  J Biomech Eng       Date:  2007-04       Impact factor: 2.097

3.  Early and late outcomes of total repair of tetralogy of Fallot: risk factors for late right ventricular dilatation.

Authors:  Hyungtae Kim; Si Chan Sung; Si-Ho Kim; Yun Hee Chang; Hyoung Doo Lee; Ji Ae Park; Young Seok Lee
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-08-15

4.  Percutaneous pulmonic valve implantation.

Authors:  Arun Kumar; Clifford Kavinsky; Zahid Amin; Ziyad M Hijazi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-12

Review 5.  The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot.

Authors:  Frederic Dallaire; Rachel M Wald; Ariane Marelli
Journal:  Pediatr Cardiol       Date:  2017-06-16       Impact factor: 1.655

6.  Pulmonary regurgitation is a powerful factor influencing QRS duration in patients after surgical repair of tetralogy of Fallot. A magnetic resonance imaging (MRI) study.

Authors:  M Grothoff; B Spors; H Abdul-Khaliq; M Abd El Rahman; V Alexi-Meskishvili; P Lange; R Felix; M Gutberlet
Journal:  Clin Res Cardiol       Date:  2006-10-10       Impact factor: 5.460

7.  Physiologic and molecular characterization of a murine model of right ventricular volume overload.

Authors:  Sushma Reddy; Mingming Zhao; Dong-Qing Hu; Giovanni Fajardo; Ethan Katznelson; Rajesh Punn; Joshua M Spin; Frandics P Chan; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-15       Impact factor: 4.733

8.  Severe pulmonary regurgitation late after total repair of tetralogy of Fallot: surgical considerations.

Authors:  A Borowski; A Ghodsizad; J Litmathe; W Lawrenz; K G Schmidt; E Gams
Journal:  Pediatr Cardiol       Date:  2004-03-04       Impact factor: 1.655

9.  Evaluation of postoperative pulmonary regurgitation after surgical repair of tetralogy of Fallot: comparison between Doppler echocardiography and MR velocity mapping.

Authors:  Matthias Grothoff; Birgit Spors; Hasim Abdul-Khaliq; Matthias Gutberlet
Journal:  Pediatr Radiol       Date:  2007-11-27

10.  Three-dimensional analysis of regional right ventricular shape and function in repaired tetralogy of Fallot using cardiovascular magnetic resonance.

Authors:  S Javed Zaidi; Waseem Cossor; Amita Singh; Francesco Maffesanti; Keigo Kawaji; Joyce Woo; Victor Mor-Avi; David A Roberson; Shelby Kutty; Amit R Patel
Journal:  Clin Imaging       Date:  2018-07-07       Impact factor: 1.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.